Single Center, Randomized, Double-Blind, Placebo-Controlled Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Infliximab (Primary) ; Methylprednisolone acetate
- Indications Osteoarthritis
- Focus Biomarker; Therapeutic Use
- 09 Nov 2011 Results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 11 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 11 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.